Accustem Sciences ACUT
OTC ACUT
$0.16 -0.06 (-28.89%)
As of: Aug 21, 2026 · 2:06 PM EDT

Accustem Sciences (ACUT) Property, Plant & Equipment (Net) (2022 - 2025)

Accustem Sciences (ACUT) Property, Plant & Equipment (Net) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Accustem Sciences 2.57 Mn 2.56 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 105.00
Mar 31, 2025 105.00
Dec 31, 2024 418.00
Dec 31, 2024 418.00
Sep 30, 2024 1,325.00
Sep 30, 2024 1,325.00
Jun 30, 2024 2,233.00
Jun 30, 2024 2,233.00
Mar 31, 2024 3,140.00
Mar 31, 2024 3,140.00
Dec 31, 2023 4,048.00
Dec 31, 2023 4,048.00
Sep 30, 2023 4,955.00
Sep 30, 2023 4,955.00
Jun 30, 2023 5,863.00
Jun 30, 2023 5,863.00
Mar 31, 2023 6,770.00
Mar 31, 2023 6,770.00
Dec 31, 2022 7,678.00
Dec 31, 2022 7,678.00